Patents/Assignees

Alnylam Pharmaceuticals, Inc.

82 patents in portfolio

US12173289utility2024
Hepatitis B Virus (HBV) Dsrna Agent Compositions and Methods of Use Thereof
0 cites
US12168767utility2024
Modified Double-stranded RNA Agents
0 cites
US12091666utility2024
Xanthine Dehydrogenase (XDH) Irna Compositions and Methods of Use Thereof
0 cites
US12071619utility2024
SERPINA1 Irna Compositions and Methods of Use Thereof
0 cites
US12059468utility2024
Carbohydrate Conjugates as Delivery Agents for Oligonucleotides
0 cites
US12049628utility2024
Transthyretin (TTR) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-associated Diseases
0 cites
US12049630utility2024
Factor XII (F12) Irna Compositions and Methods of Use Thereof
0 cites
US12031133utility2024
GNAQ Targeted Dsrna Compositions and Methods for Inhibiting Expression
0 cites
US12018260utility2024
Tunable Reversir™ Compounds
0 cites
US12005074utility2024
Extrahepatic Delivery
0 cites
US11993774utility2024
Huntingtin (HTT) Irna Agent Compositions and Methods of Use Thereof
0 cites
US11987792utility2024
Compositions and Methods for Inhibiting Expression of the LECT2 Gene
0 cites
US11965166utility2024
Complement Factor B (CFB) Irna Compositions and Methods of Use Thereof
0 cites
US11959081utility2024
Transthyretin (TTR) Irna Compositions and Methods of Use Thereof
0 cites
US11944687utility2024
Carbohydrate Conjugate RNA Agents and Process for Their Preparation
0 cites
US11926832utility2024
Ketohexokinase (KHK) Irna Compositions and Methods of Use Thereof
0 cites
US11884919utility2024
Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid a Gene
0 cites
US11873491utility2024
Complement Component C5 Irna Compositions and Methods of Use Thereof
0 cites
US11866701utility2024
Complement Component C3 Irna Compositions and Methods of Use Thereof
0 cites
US11866709utility2024
Angiopoietin-like 3 (ANGPTL3) Irna Compositions and Methods of Use Thereof
0 cites

← PreviousPage 3 of 5Next →